Skip to main content

18-06-2020 | Haematology | Video

EHA25 | Support for two-dose influenza vaccine schedule after autologous HSCT

Benjamin Teh presents trial data showing high seroprotection rates against all strains with a two-dose schedule of seasonal influenza vaccination, irrespective of vaccine type, in individuals who have undergone autologous haematopoietic stem cell transplantation (5:56).

Funding for independent interviews at EHA25 was provided by F. Hoffmann-La Roche Ltd, Basel, Switzerland.

Image Credits